Cargando…

CAR T-cell therapy for triple-class exposed relapsed/refractory multiple myeloma

Detalles Bibliográficos
Autor principal: Cavo, Michele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388261/
https://www.ncbi.nlm.nih.gov/pubmed/37021536
http://dx.doi.org/10.3324/haematol.2022.282587
_version_ 1785082074575667200
author Cavo, Michele
author_facet Cavo, Michele
author_sort Cavo, Michele
collection PubMed
description
format Online
Article
Text
id pubmed-10388261
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Fondazione Ferrata Storti
record_format MEDLINE/PubMed
spelling pubmed-103882612023-08-01 CAR T-cell therapy for triple-class exposed relapsed/refractory multiple myeloma Cavo, Michele Haematologica Editorial Fondazione Ferrata Storti 2023-04-06 /pmc/articles/PMC10388261/ /pubmed/37021536 http://dx.doi.org/10.3324/haematol.2022.282587 Text en Copyright© 2023 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Editorial
Cavo, Michele
CAR T-cell therapy for triple-class exposed relapsed/refractory multiple myeloma
title CAR T-cell therapy for triple-class exposed relapsed/refractory multiple myeloma
title_full CAR T-cell therapy for triple-class exposed relapsed/refractory multiple myeloma
title_fullStr CAR T-cell therapy for triple-class exposed relapsed/refractory multiple myeloma
title_full_unstemmed CAR T-cell therapy for triple-class exposed relapsed/refractory multiple myeloma
title_short CAR T-cell therapy for triple-class exposed relapsed/refractory multiple myeloma
title_sort car t-cell therapy for triple-class exposed relapsed/refractory multiple myeloma
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388261/
https://www.ncbi.nlm.nih.gov/pubmed/37021536
http://dx.doi.org/10.3324/haematol.2022.282587
work_keys_str_mv AT cavomichele cartcelltherapyfortripleclassexposedrelapsedrefractorymultiplemyeloma